Sure Pulse Medical

25/03/2026

New research (Lakshminrusimha et al., 2026) highlights ongoing uncertainty around the optimal initial oxygen concentration for resuscitating preterm infants (

The optimal initial oxygen concentration for resuscitation and stabilization of preterm infants (

23/03/2026

Traditional ECG heart rate monitoring isn’t designed for newborns.

❌ Slow to attach & prone to dislodgement (Mizumoto, 2012)
❌ Risk of damaging delicate newborn skin (Anton, 2019)
❌ Wires interfere with crucial delivery room cuddles & kangaroo care (Bonner, 2017)

At SurePulse, we’re transforming neonatal monitoring with solutions designed to make it safer, faster, and more family-friendly. Discover more about these challenges: https://buff.ly/ZDf0ewU

17/03/2026

Excited to share that SurePulse Medical has been selected to pitch at the MedTech Innovator Virtual Radar Event on the 26th of March!

We’re proud to be in the top 10% of over 1,800 applicants invited to compete for a spot in the MedTech Innovator Accelerator.

Dr James Carpenter will present our new multi-parameter, wireless, vital sign monitoring for newborns to an audience of 90+ investors, strategics, clinicians, and industry leaders helping shape the future of medtech.

13/03/2026

Great to be at the Dresden Symposium discussing the latest research aimed at improving care for newborns.

Fantastic to see Prof Don Sharkey sharing our progress on next-generation vital sign monitoring in the delivery room and how new technology can support clinical teams at those critical first moments of life.

10/03/2026

Medilink Midlands has spotlighted SurePulse’s simulation study in a new case study exploring how MeTAP programme support is helping advance neonatal monitoring innovation.

The study uses simulation to evaluate technologies designed to improve monitoring of newborn babies during critical moments of care.

🔎 Read the full case study:
https://www.medilinkmidlands.com/wp-content/uploads/2026/03/SurePulse-MeTAP-Case-Study.pdf

At a glance: Company: SurePulse Sector: MedTech / Neonatal Care MeTAP support accessed: Grant funding, clinical simulation coordination, neonatal expertise, video capture and advisory support Key outcome: Workflow validation of […]

09/03/2026

Promoting family-integrated care is essential for exceptional neonatal practice. SurePulse wireless vital sign monitoring enables better skin-to-skin bonding, letting parents cuddle and care for their baby after birth while ensuring continuous monitoring. Learn more: https://buff.ly/3VuaVVi

04/03/2026

Dr Anne Maire Heuchan, Consultant Neonatologist at Glasgow Children’s Hospital discusses the challenges of monitoring heart rate at birth.

Find out more about our wireless heart rate monitoring solutions for the delivery room: https://buff.ly/0hBds9J

02/03/2026

We’re looking forward to attending the 17th Dresden Symposium
🗓 March 12–13, 2026
📍 Dresden, Germany

The symposium is a key platform for intensive discussion around Delivery Room Management and the latest developments in neonatology, bringing together clinicians and companies dedicated to improving newborn care.

We’re excited to be there in person and engage with peers committed to advancing care at birth.

26/02/2026

Researchers in California have published a study reporting that that deferred cord clamping (DCC) for at least 30 seconds is associated with a modest but statistically significant increase in first-recorded weight among very preterm infants (

23/02/2026

Did you know that 10% of newborns—that’s 380,000 babies each year in the U.S.—require stabilization after birth?

Failure to keep newborns within safe vital sign parameters can have serious consequences. For example, if a baby’s heart rate stays below 100 bpm for just 2 minutes, the risk of death increases 5-fold. (Kapadia)

That’s why we developed SurePulse VS—a wireless heart rate monitoring Cap that delivers quick, accurate, real-time data when every second matters.

Because timely intervention saves lives.

18/02/2026

Optimal cord clamping (OCC) offers vital benefits for newborns; improved oxygenation, higher iron stores, and better cardiovascular stability. Yet, in critical moments, ensuring a baby’s well-being while keeping the cord intact can be challenging. Traditional monitoring methods often require clamping and cutting the cord early to assess vital signs quickly.

What if we could do both?

With SurePulse wireless vital sign monitoring, we can provide provide clinical teams with accurate, reliable, and timely information in the critical moments after birth. This means:

✅ Real-time vital sign monitoring while the cord remains intact
✅ Supporting clinical decision-making without premature cord clamping

Read our article on the latest Optimal Cord Clamping Guidelines https://buff.ly/3XgHO8M

16/02/2026

Last year we shared the findings of an independent review by the UK Department of Health & Social Care which highlighted concerns about racial bias in medical devices, particularly in pulse oximeters. Research shows that these devices overestimate oxygen levels in patients with darker skin tones, potentially delaying critical care.

In neonatal care, accurate monitoring is vital. That’s why SurePulse VS stands out. Designed to provide precise and reliable heart rate monitoring for newborns, regardless of skin tone. This innovation ensures equitable and optimal care for all babies from birth.

📖 Read more here: https://buff.ly/40WqEzB